Genetic Disorders Research
Lilly and Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, want to develop and make gene therapies to meet the needs of people living with genetic conditions. Through clinical research we are looking to find out if investigational genetic medicines may help people with genetic disorders such as:
- Gaucher disease (type 1 & 2)
- Parkinson’s disease with a GBA1 gene mutation
- Frontotemporal dementia with a progranulin (GRN) gene mutation
By taking part in a clinical research study, you can help to make a difference. Click here to view clinical trials for neurological disorders.